Advertisement

Index by author

April 01, 1994; Volume 45,Issue 4

A

  1. Abdel-Hamid, K

    1. Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons.
      J Church, E J Fletcher, K Abdel-Hamid and J F MacDonald
      Molecular Pharmacology April 1994, 45 (4) 747-757;

  2. Agbaria, R

    1. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
      R Agbaria, C A Mullen, N R Hartman, D A Cooney, Z Hao, R M Blaese and D G Johns
      Molecular Pharmacology April 1994, 45 (4) 777-782;

  3. Ahern, D

    1. Identification and characterization of a lysophosphatidic acid receptor.
      F J Thomson, L Perkins, D Ahern and M Clark
      Molecular Pharmacology April 1994, 45 (4) 718-723;

  4. Alvira, M

    1. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.
      E Falck-Pedersen, M Heinflink, M Alvira, D R Nussenzveig and M C Gershengorn
      Molecular Pharmacology April 1994, 45 (4) 684-689;

B

  1. Badio, B

    1. Epibatidine, a potent analgetic and nicotinic agonist.
      B Badio and J W Daly
      Molecular Pharmacology April 1994, 45 (4) 563-569;

  2. Balestrieri, M L

    1. Docosahexaenoic acid and signaling pathways in rabbit colon.
      V Calderaro, C Parrillo, M L Balestrieri, A Giovane, A Filippelli and F Rossi
      Molecular Pharmacology April 1994, 45 (4) 737-746;

  3. Bard, J A

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  4. Bell, G I

    1. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
      S F Law, S Zaina, R Sweet, K Yasuda, G I Bell, J Stadel and T Reisine
      Molecular Pharmacology April 1994, 45 (4) 587-590;

  5. Blaese, R M

    1. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
      R Agbaria, C A Mullen, N R Hartman, D A Cooney, Z Hao, R M Blaese and D G Johns
      Molecular Pharmacology April 1994, 45 (4) 777-782;

  6. Boarder, M R

    1. Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells.
      G F Wilkinson, J R Purkiss and M R Boarder
      Molecular Pharmacology April 1994, 45 (4) 731-736;

  7. Bockaert, J

    1. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures.
      L Prézeau, J Carrette, B Helpap, K Curry, J P Pin and J Bockaert
      Molecular Pharmacology April 1994, 45 (4) 570-577;

  8. Bouisson, M

    1. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
      S S Poirot, C Escrieut, M Dufresne, J Martinez, M Bouisson, N Vaysse and D Fourmy
      Molecular Pharmacology April 1994, 45 (4) 599-607;

  9. Branchek, T A

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  10. Buckpitt, A R

    1. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells.
      C H Chichester, A R Buckpitt, A Chang and C G Plopper
      Molecular Pharmacology April 1994, 45 (4) 664-672;

C

  1. Calderaro, V

    1. Docosahexaenoic acid and signaling pathways in rabbit colon.
      V Calderaro, C Parrillo, M L Balestrieri, A Giovane, A Filippelli and F Rossi
      Molecular Pharmacology April 1994, 45 (4) 737-746;

  2. Cardarelli, C

    1. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
      W D Stein, C Cardarelli, I Pastan and M M Gottesman
      Molecular Pharmacology April 1994, 45 (4) 763-772;

  3. Caron, M G

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  4. Carrette, J

    1. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures.
      L Prézeau, J Carrette, B Helpap, K Curry, J P Pin and J Bockaert
      Molecular Pharmacology April 1994, 45 (4) 570-577;

  5. Catania, M V

    1. Metabotropic glutamate receptor heterogeneity in rat brain.
      M V Catania, H De Socarraz, J B Penney and A B Young
      Molecular Pharmacology April 1994, 45 (4) 626-636;

  6. Chang, A

    1. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells.
      C H Chichester, A R Buckpitt, A Chang and C G Plopper
      Molecular Pharmacology April 1994, 45 (4) 664-672;

  7. Charlton, M E

    1. Quantitative changes in alpha 1 and alpha 5 gamma-aminobutyric acid type A receptor subunit mRNAs and proteins after a single treatment of cerebellar granule neurons with N-methyl-D-aspartate.
      B T Harris, M E Charlton, E Costa and D R Grayson
      Molecular Pharmacology April 1994, 45 (4) 637-648;

  8. Chichester, C H

    1. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells.
      C H Chichester, A R Buckpitt, A Chang and C G Plopper
      Molecular Pharmacology April 1994, 45 (4) 664-672;

  9. Chiu, G

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  10. Chiu, T H

    1. Reduced expression of gamma-aminobutyric acid type A/benzodiazepine receptor gamma 2 and alpha 5 subunit mRNAs in brain regions of flurazepam-treated rats.
      T J Zhao, T H Chiu and H C Rosenberg
      Molecular Pharmacology April 1994, 45 (4) 657-663;

  11. Church, J

    1. Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons.
      J Church, E J Fletcher, K Abdel-Hamid and J F MacDonald
      Molecular Pharmacology April 1994, 45 (4) 747-757;

  12. Clark, M

    1. Identification and characterization of a lysophosphatidic acid receptor.
      F J Thomson, L Perkins, D Ahern and M Clark
      Molecular Pharmacology April 1994, 45 (4) 718-723;

  13. Cooney, D A

    1. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
      R Agbaria, C A Mullen, N R Hartman, D A Cooney, Z Hao, R M Blaese and D G Johns
      Molecular Pharmacology April 1994, 45 (4) 777-782;

  14. Costa, E

    1. Quantitative changes in alpha 1 and alpha 5 gamma-aminobutyric acid type A receptor subunit mRNAs and proteins after a single treatment of cerebellar granule neurons with N-methyl-D-aspartate.
      B T Harris, M E Charlton, E Costa and D R Grayson
      Molecular Pharmacology April 1994, 45 (4) 637-648;

  15. Curry, K

    1. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures.
      L Prézeau, J Carrette, B Helpap, K Curry, J P Pin and J Bockaert
      Molecular Pharmacology April 1994, 45 (4) 570-577;

D

  1. Daly, J W

    1. Epibatidine, a potent analgetic and nicotinic agonist.
      B Badio and J W Daly
      Molecular Pharmacology April 1994, 45 (4) 563-569;

  2. De Socarraz, H

    1. Metabotropic glutamate receptor heterogeneity in rat brain.
      M V Catania, H De Socarraz, J B Penney and A B Young
      Molecular Pharmacology April 1994, 45 (4) 626-636;

  3. Drechsler, H

    1. p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs.
      S Pötsch, H Drechsler, B Liermann, A Gräslund and G Lassmann
      Molecular Pharmacology April 1994, 45 (4) 792-796;

  4. Dufresne, M

    1. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
      S S Poirot, C Escrieut, M Dufresne, J Martinez, M Bouisson, N Vaysse and D Fourmy
      Molecular Pharmacology April 1994, 45 (4) 599-607;

E

  1. Eason, M G

    1. Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs.
      M G Eason, M T Jacinto and S B Liggett
      Molecular Pharmacology April 1994, 45 (4) 696-702;

  2. Engel, M

    1. Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.
      I Posner, M Engel, A Gazit and A Levitzki
      Molecular Pharmacology April 1994, 45 (4) 673-683;

  3. Esbenshade, T A

    1. Increased voltage-dependent calcium influx produced by alpha 1B-adrenergic receptor activation in rat medullary thyroid carcinoma 6-23 cells.
      T A Esbenshade, T L Theroux and K P Minneman
      Molecular Pharmacology April 1994, 45 (4) 591-598;

  4. Escrieut, C

    1. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
      S S Poirot, C Escrieut, M Dufresne, J Martinez, M Bouisson, N Vaysse and D Fourmy
      Molecular Pharmacology April 1994, 45 (4) 599-607;

F

  1. Falck-Pedersen, E

    1. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.
      E Falck-Pedersen, M Heinflink, M Alvira, D R Nussenzveig and M C Gershengorn
      Molecular Pharmacology April 1994, 45 (4) 684-689;

  2. Filippelli, A

    1. Docosahexaenoic acid and signaling pathways in rabbit colon.
      V Calderaro, C Parrillo, M L Balestrieri, A Giovane, A Filippelli and F Rossi
      Molecular Pharmacology April 1994, 45 (4) 737-746;

  3. Fletcher, E J

    1. Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons.
      J Church, E J Fletcher, K Abdel-Hamid and J F MacDonald
      Molecular Pharmacology April 1994, 45 (4) 747-757;

  4. Fong, T M

    1. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.
      R R Huang, H Yu, C D Strader and T M Fong
      Molecular Pharmacology April 1994, 45 (4) 690-695;

  5. Fornari, F A

    1. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
      F A Fornari, J K Randolph, J C Yalowich, M K Ritke and D A Gewirtz
      Molecular Pharmacology April 1994, 45 (4) 649-656;

  6. Forray, C

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  7. Fourmy, D

    1. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
      S S Poirot, C Escrieut, M Dufresne, J Martinez, M Bouisson, N Vaysse and D Fourmy
      Molecular Pharmacology April 1994, 45 (4) 599-607;

G

  1. Galivan, J

    1. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
      M S Rhee, J Galivan, J E Wright and A Rosowsky
      Molecular Pharmacology April 1994, 45 (4) 783-791;

  2. Gazit, A

    1. Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.
      I Posner, M Engel, A Gazit and A Levitzki
      Molecular Pharmacology April 1994, 45 (4) 673-683;

  3. Gershengorn, M C

    1. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.
      E Falck-Pedersen, M Heinflink, M Alvira, D R Nussenzveig and M C Gershengorn
      Molecular Pharmacology April 1994, 45 (4) 684-689;

  4. Gewirtz, D A

    1. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
      F A Fornari, J K Randolph, J C Yalowich, M K Ritke and D A Gewirtz
      Molecular Pharmacology April 1994, 45 (4) 649-656;

  5. Giovane, A

    1. Docosahexaenoic acid and signaling pathways in rabbit colon.
      V Calderaro, C Parrillo, M L Balestrieri, A Giovane, A Filippelli and F Rossi
      Molecular Pharmacology April 1994, 45 (4) 737-746;

  6. Giros, B

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  7. Godinot, N

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  8. Gottesman, M M

    1. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
      W D Stein, C Cardarelli, I Pastan and M M Gottesman
      Molecular Pharmacology April 1994, 45 (4) 763-772;

  9. Gräslund, A

    1. p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs.
      S Pötsch, H Drechsler, B Liermann, A Gräslund and G Lassmann
      Molecular Pharmacology April 1994, 45 (4) 792-796;

  10. Grayson, D R

    1. Quantitative changes in alpha 1 and alpha 5 gamma-aminobutyric acid type A receptor subunit mRNAs and proteins after a single treatment of cerebellar granule neurons with N-methyl-D-aspartate.
      B T Harris, M E Charlton, E Costa and D R Grayson
      Molecular Pharmacology April 1994, 45 (4) 637-648;

  11. Grünbaum, L

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

H

  1. Hagelüken, A

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  2. Han, H

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  3. Hao, Z

    1. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
      R Agbaria, C A Mullen, N R Hartman, D A Cooney, Z Hao, R M Blaese and D G Johns
      Molecular Pharmacology April 1994, 45 (4) 777-782;

  4. Harris, B T

    1. Quantitative changes in alpha 1 and alpha 5 gamma-aminobutyric acid type A receptor subunit mRNAs and proteins after a single treatment of cerebellar granule neurons with N-methyl-D-aspartate.
      B T Harris, M E Charlton, E Costa and D R Grayson
      Molecular Pharmacology April 1994, 45 (4) 637-648;

  5. Hartig, P R

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  6. Hartman, N R

    1. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
      R Agbaria, C A Mullen, N R Hartman, D A Cooney, Z Hao, R M Blaese and D G Johns
      Molecular Pharmacology April 1994, 45 (4) 777-782;

  7. Heinflink, M

    1. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.
      E Falck-Pedersen, M Heinflink, M Alvira, D R Nussenzveig and M C Gershengorn
      Molecular Pharmacology April 1994, 45 (4) 684-689;

  8. Helpap, B

    1. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures.
      L Prézeau, J Carrette, B Helpap, K Curry, J P Pin and J Bockaert
      Molecular Pharmacology April 1994, 45 (4) 570-577;

  9. Höer, A

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  10. Höer, D

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  11. Hu, X J

    1. Chronic benzodiazepine agonist treatment produces functional uncoupling of the gamma-aminobutyric acid-benzodiazepine receptor ionophore complex in cortical neurons.
      X J Hu and M K Ticku
      Molecular Pharmacology April 1994, 45 (4) 618-625;

  12. Huang, R R

    1. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.
      R R Huang, H Yu, C D Strader and T M Fong
      Molecular Pharmacology April 1994, 45 (4) 690-695;

  13. Hunsaker, L A

    1. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity.
      N S Kolb, L A Hunsaker and D L Vander Jagt
      Molecular Pharmacology April 1994, 45 (4) 797-801;

J

  1. Jacinto, M T

    1. Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs.
      M G Eason, M T Jacinto and S B Liggett
      Molecular Pharmacology April 1994, 45 (4) 696-702;

  2. Johns, D G

    1. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
      R Agbaria, C A Mullen, N R Hartman, D A Cooney, Z Hao, R M Blaese and D G Johns
      Molecular Pharmacology April 1994, 45 (4) 777-782;

K

  1. Kase, H

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  2. Kim, K M

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  3. Kingsmore, S F

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  4. Kolb, N S

    1. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity.
      N S Kolb, L A Hunsaker and D L Vander Jagt
      Molecular Pharmacology April 1994, 45 (4) 797-801;

L

  1. Lassmann, G

    1. p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs.
      S Pötsch, H Drechsler, B Liermann, A Gräslund and G Lassmann
      Molecular Pharmacology April 1994, 45 (4) 792-796;

  2. Law, S F

    1. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
      S F Law, S Zaina, R Sweet, K Yasuda, G I Bell, J Stadel and T Reisine
      Molecular Pharmacology April 1994, 45 (4) 587-590;

  3. Lepor, H

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  4. Levitzki, A

    1. Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.
      I Posner, M Engel, A Gazit and A Levitzki
      Molecular Pharmacology April 1994, 45 (4) 673-683;

  5. Liermann, B

    1. p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs.
      S Pötsch, H Drechsler, B Liermann, A Gräslund and G Lassmann
      Molecular Pharmacology April 1994, 45 (4) 792-796;

  6. Liggett, S B

    1. Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs.
      M G Eason, M T Jacinto and S B Liggett
      Molecular Pharmacology April 1994, 45 (4) 696-702;

M

  1. MacDonald, J F

    1. Loperamide blocks high-voltage-activated calcium channels and N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurons.
      J Church, E J Fletcher, K Abdel-Hamid and J F MacDonald
      Molecular Pharmacology April 1994, 45 (4) 747-757;

  2. Martinez, J

    1. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
      S S Poirot, C Escrieut, M Dufresne, J Martinez, M Bouisson, N Vaysse and D Fourmy
      Molecular Pharmacology April 1994, 45 (4) 599-607;

  3. Matsuda, Y

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  4. Minneman, K P

    1. Increased voltage-dependent calcium influx produced by alpha 1B-adrenergic receptor activation in rat medullary thyroid carcinoma 6-23 cells.
      T A Esbenshade, T L Theroux and K P Minneman
      Molecular Pharmacology April 1994, 45 (4) 591-598;

  5. Mullen, C A

    1. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
      R Agbaria, C A Mullen, N R Hartman, D A Cooney, Z Hao, R M Blaese and D G Johns
      Molecular Pharmacology April 1994, 45 (4) 777-782;

N

  1. Nonaka, H

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  2. Nozawa, M

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  3. Nussenzveig, D R

    1. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.
      E Falck-Pedersen, M Heinflink, M Alvira, D R Nussenzveig and M C Gershengorn
      Molecular Pharmacology April 1994, 45 (4) 684-689;

O

  1. Offermanns, S

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  2. Ohno, T

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  3. Oswald, R E

    1. The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition.
      G A Stafford, R E Oswald and G A Weiland
      Molecular Pharmacology April 1994, 45 (4) 758-762;

P

  1. Parrillo, C

    1. Docosahexaenoic acid and signaling pathways in rabbit colon.
      V Calderaro, C Parrillo, M L Balestrieri, A Giovane, A Filippelli and F Rossi
      Molecular Pharmacology April 1994, 45 (4) 737-746;

  2. Pastan, I

    1. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
      W D Stein, C Cardarelli, I Pastan and M M Gottesman
      Molecular Pharmacology April 1994, 45 (4) 763-772;

  3. Penney, J B

    1. Metabotropic glutamate receptor heterogeneity in rat brain.
      M V Catania, H De Socarraz, J B Penney and A B Young
      Molecular Pharmacology April 1994, 45 (4) 626-636;

  4. Perkins, L

    1. Identification and characterization of a lysophosphatidic acid receptor.
      F J Thomson, L Perkins, D Ahern and M Clark
      Molecular Pharmacology April 1994, 45 (4) 718-723;

  5. Pin, J P

    1. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures.
      L Prézeau, J Carrette, B Helpap, K Curry, J P Pin and J Bockaert
      Molecular Pharmacology April 1994, 45 (4) 570-577;

  6. Plopper, C G

    1. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells.
      C H Chichester, A R Buckpitt, A Chang and C G Plopper
      Molecular Pharmacology April 1994, 45 (4) 664-672;

  7. Poirot, S S

    1. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
      S S Poirot, C Escrieut, M Dufresne, J Martinez, M Bouisson, N Vaysse and D Fourmy
      Molecular Pharmacology April 1994, 45 (4) 599-607;

  8. Posner, I

    1. Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.
      I Posner, M Engel, A Gazit and A Levitzki
      Molecular Pharmacology April 1994, 45 (4) 673-683;

  9. Pötsch, S

    1. p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs.
      S Pötsch, H Drechsler, B Liermann, A Gräslund and G Lassmann
      Molecular Pharmacology April 1994, 45 (4) 792-796;

  10. Prézeau, L

    1. Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures.
      L Prézeau, J Carrette, B Helpap, K Curry, J P Pin and J Bockaert
      Molecular Pharmacology April 1994, 45 (4) 570-577;

  11. Proska, J

    1. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
      J Proska and S Tucek
      Molecular Pharmacology April 1994, 45 (4) 709-717;

  12. Purkiss, J R

    1. Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells.
      G F Wilkinson, J R Purkiss and M R Boarder
      Molecular Pharmacology April 1994, 45 (4) 731-736;

R

  1. Randolph, J K

    1. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
      F A Fornari, J K Randolph, J C Yalowich, M K Ritke and D A Gewirtz
      Molecular Pharmacology April 1994, 45 (4) 649-656;

  2. Rao, U S

    1. Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.
      U S Rao and G A Scarborough
      Molecular Pharmacology April 1994, 45 (4) 773-776;

  3. Reisine, T

    1. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
      S F Law, S Zaina, R Sweet, K Yasuda, G I Bell, J Stadel and T Reisine
      Molecular Pharmacology April 1994, 45 (4) 587-590;

  4. Rhee, M S

    1. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
      M S Rhee, J Galivan, J E Wright and A Rosowsky
      Molecular Pharmacology April 1994, 45 (4) 783-791;

  5. Ritke, M K

    1. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
      F A Fornari, J K Randolph, J C Yalowich, M K Ritke and D A Gewirtz
      Molecular Pharmacology April 1994, 45 (4) 649-656;

  6. Rosenberg, H C

    1. Reduced expression of gamma-aminobutyric acid type A/benzodiazepine receptor gamma 2 and alpha 5 subunit mRNAs in brain regions of flurazepam-treated rats.
      T J Zhao, T H Chiu and H C Rosenberg
      Molecular Pharmacology April 1994, 45 (4) 657-663;

  7. Rosowsky, A

    1. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
      M S Rhee, J Galivan, J E Wright and A Rosowsky
      Molecular Pharmacology April 1994, 45 (4) 783-791;

  8. Rossi, F

    1. Docosahexaenoic acid and signaling pathways in rabbit colon.
      V Calderaro, C Parrillo, M L Balestrieri, A Giovane, A Filippelli and F Rossi
      Molecular Pharmacology April 1994, 45 (4) 737-746;

S

  1. Scarborough, G A

    1. Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.
      U S Rao and G A Scarborough
      Molecular Pharmacology April 1994, 45 (4) 773-776;

  2. Schultz, G

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  3. Schunack, W

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  4. Schwaner, I

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  5. Seifert, R

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;

  6. Seldin, M F

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  7. Shapiro, E

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  8. Stadel, J

    1. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
      S F Law, S Zaina, R Sweet, K Yasuda, G I Bell, J Stadel and T Reisine
      Molecular Pharmacology April 1994, 45 (4) 587-590;

  9. Stafford, G A

    1. The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition.
      G A Stafford, R E Oswald and G A Weiland
      Molecular Pharmacology April 1994, 45 (4) 758-762;

  10. Stein, W D

    1. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
      W D Stein, C Cardarelli, I Pastan and M M Gottesman
      Molecular Pharmacology April 1994, 45 (4) 763-772;

  11. Strader, C D

    1. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.
      R R Huang, H Yu, C D Strader and T M Fong
      Molecular Pharmacology April 1994, 45 (4) 690-695;

  12. Sweet, R

    1. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
      S F Law, S Zaina, R Sweet, K Yasuda, G I Bell, J Stadel and T Reisine
      Molecular Pharmacology April 1994, 45 (4) 587-590;

T

  1. Tanaka, T

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  2. Tang, R

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  3. Theroux, T L

    1. Increased voltage-dependent calcium influx produced by alpha 1B-adrenergic receptor activation in rat medullary thyroid carcinoma 6-23 cells.
      T A Esbenshade, T L Theroux and K P Minneman
      Molecular Pharmacology April 1994, 45 (4) 591-598;

  4. Thomson, F J

    1. Identification and characterization of a lysophosphatidic acid receptor.
      F J Thomson, L Perkins, D Ahern and M Clark
      Molecular Pharmacology April 1994, 45 (4) 718-723;

  5. Ticku, M K

    1. Chronic benzodiazepine agonist treatment produces functional uncoupling of the gamma-aminobutyric acid-benzodiazepine receptor ionophore complex in cortical neurons.
      X J Hu and M K Ticku
      Molecular Pharmacology April 1994, 45 (4) 618-625;

  6. Tsukuda, E

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  7. Tucek, S

    1. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
      J Proska and S Tucek
      Molecular Pharmacology April 1994, 45 (4) 709-717;

V

  1. Vander Jagt, D L

    1. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity.
      N S Kolb, L A Hunsaker and D L Vander Jagt
      Molecular Pharmacology April 1994, 45 (4) 797-801;

  2. Vaysse, N

    1. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
      S S Poirot, C Escrieut, M Dufresne, J Martinez, M Bouisson, N Vaysse and D Fourmy
      Molecular Pharmacology April 1994, 45 (4) 599-607;

W

  1. Weiland, G A

    1. The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition.
      G A Stafford, R E Oswald and G A Weiland
      Molecular Pharmacology April 1994, 45 (4) 758-762;

  2. Weinshank, R L

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  3. Wetzel, J M

    1. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.
      C Forray, J A Bard, J M Wetzel, G Chiu, E Shapiro, R Tang, H Lepor, P R Hartig, R L Weinshank and T A Branchek
      Molecular Pharmacology April 1994, 45 (4) 703-708;

  4. Wilkinson, G F

    1. Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells.
      G F Wilkinson, J R Purkiss and M R Boarder
      Molecular Pharmacology April 1994, 45 (4) 731-736;

  5. Wright, J E

    1. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
      M S Rhee, J Galivan, J E Wright and A Rosowsky
      Molecular Pharmacology April 1994, 45 (4) 783-791;

Y

  1. Yalowich, J C

    1. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.
      F A Fornari, J K Randolph, J C Yalowich, M K Ritke and D A Gewirtz
      Molecular Pharmacology April 1994, 45 (4) 649-656;

  2. Yamada, K

    1. RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin.
      T Tanaka, E Tsukuda, M Nozawa, H Nonaka, T Ohno, H Kase, K Yamada and Y Matsuda
      Molecular Pharmacology April 1994, 45 (4) 724-730;

  3. Yang-Feng, T L

    1. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
      K M Kim, S F Kingsmore, H Han, T L Yang-Feng, N Godinot, M F Seldin, M G Caron and B Giros
      Molecular Pharmacology April 1994, 45 (4) 608-617;

  4. Yasuda, K

    1. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
      S F Law, S Zaina, R Sweet, K Yasuda, G I Bell, J Stadel and T Reisine
      Molecular Pharmacology April 1994, 45 (4) 587-590;

  5. Young, A B

    1. Metabotropic glutamate receptor heterogeneity in rat brain.
      M V Catania, H De Socarraz, J B Penney and A B Young
      Molecular Pharmacology April 1994, 45 (4) 626-636;

  6. Yu, H

    1. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.
      R R Huang, H Yu, C D Strader and T M Fong
      Molecular Pharmacology April 1994, 45 (4) 690-695;

Z

  1. Zaina, S

    1. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
      S F Law, S Zaina, R Sweet, K Yasuda, G I Bell, J Stadel and T Reisine
      Molecular Pharmacology April 1994, 45 (4) 587-590;

  2. Zhao, T J

    1. Reduced expression of gamma-aminobutyric acid type A/benzodiazepine receptor gamma 2 and alpha 5 subunit mRNAs in brain regions of flurazepam-treated rats.
      T J Zhao, T H Chiu and H C Rosenberg
      Molecular Pharmacology April 1994, 45 (4) 657-663;

  3. Zingel, V

    1. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes.
      R Seifert, A Hagelüken, A Höer, D Höer, L Grünbaum, S Offermanns, I Schwaner, V Zingel, W Schunack and G Schultz
      Molecular Pharmacology April 1994, 45 (4) 578-586;
Back to top

In this issue

Advertisement